HWAM
REGN icon

Hennion & Walsh Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Hennion & Walsh Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$446K Buy
715
+3
+0.4% +$2.04K 0.01% 771
2026
Q1 		$550K Sell
712
-306
-30% -$234K 0.02% 690
2025
Q4 		$786K Sell
1,018
-29
-3% -$19.7K 0.03% 582
2025
Q3 		$589K Sell
1,047
-1,206
-54% -$682K 0.02% 667
2025
Q2 		$1.18M Sell
2,253
-90
-4% -$50.2K 0.05% 457
2025
Q1 		$1.49M Sell
2,343
-763
-25% -$525K 0.07% 356
2024
Q4 		$2.21M Buy
3,106
+99
+3% +$83.1K 0.1% 262
2024
Q3 		$3.16M Buy
3,007
+524
+21% +$583K 0.15% 185
2024
Q2 		$2.61M Buy
2,483
+118
+5% +$114K 0.13% 202
2024
Q1 		$2.28M Buy
2,365
+426
+22% +$405K 0.12% 229
2023
Q4 		$1.7M Buy
1,939
+344
+22% +$283K 0.1% 271
2023
Q3 		$1.31M Buy
1,595
+344
+27% +$270K 0.08% 299
2023
Q2 		$899K Buy
1,251
+327
+35% +$252K 0.05% 391
2023
Q1 		$759K Sell
924
-1,152
-55% -$869K 0.05% 415
2022
Q4 		$1.5M Sell
2,076
-127
-6% -$93.7K 0.09% 259
2022
Q3 		$1.52M Sell
2,203
-260
-11% -$164K 0.1% 240
2022
Q2 		$1.46M Sell
2,463
-1,087
-31% -$707K 0.09% 247
2022
Q1 		$2.48M Buy
3,550
+123
+4% +$77.8K 0.13% 196
2021
Q4 		$2.16M Buy
3,427
+154
+5% +$94.7K 0.11% 222
2021
Q3 		$1.98M Buy
3,273
+420
+15% +$261K 0.1% 241
2021
Q2 		$1.59M Buy
2,853
+444
+18% +$225K 0.09% 273
2021
Q1 		$1.14M Buy
+2,409
New +$1.17M 0.07% 336

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Hennion & Walsh Asset Management's REGN Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 0.42% in Q2 2026, buying an estimated $2.04K and bringing the position to 715 shares worth $446K. The position accounts for 0.01% of the portfolio, ranked #771.

Hennion & Walsh Asset Management first reported a position in REGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.16M in Q3 2024. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Hennion & Walsh Asset Management held 715 shares of Regeneron Pharmaceuticals worth $446K as of Q2 2026.
  • Hennion & Walsh Asset Management bought 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
  • Regeneron Pharmaceuticals made up 0.01% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #771 holding.
  • Hennion & Walsh Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Hennion & Walsh Asset Management's Regeneron Pharmaceuticals position peaked at $3.16M in Q3 2024.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.